[Close]
- This page was created by volunteers like you!
- Help us make it even better. To learn more about contributing to MEpedia, click here.
- Join the movement
- Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
- Congratulations!
- MEpedia has got over 30 million views as of August 2022!
Reishi mushroom
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from Reishi)
Reishi or ganoderma lucidum or lingzhi is a mushroom of the Ganodermataceae family and contain much triterpene, which works against inflammation. Reishi mushrooms have a similar effect to cortisone but help the body in a natural way.[citation needed] Reishi activates and supports the immune system.[1] Iwatsuki et al. (2013) found reishi inhibits the activation of Epstein-Barr virus.[2]
ME/CFS[edit | edit source]
Evidence[edit | edit source]
It is used in the treatment regime against ME of Ms Katrina Voss to prevent the use of Raltegravir.
A small trial by Soksawatmakhin et al. (2013) found that a dose of 500mg or reishi extract four times per day resulted in a clinically significant improvement in patients with unexplained chronic fatigue meeting the NICE guidelines criteria for CFS/ME.[3]
Notable studies[edit | edit source]
- 2013, Preliminary study of the applications of Ganoderma lucidum in chronic fatigue syndrome[3](Full text)
Learn more[edit | edit source]
- Reishi mushroom: uses and risks - WebMD
- Gandoderma - Longevis
See also[edit | edit source]
References[edit | edit source]
- ↑ Ganoderma — A Therapeutic Fungal Biofactory
- ↑ Iwatsuki, Kenji; Akihisa, Toshihiro; Tokuda, Harukuni; Ukiya, Motohiko; Oshikubo, Manabu; Kimura, Yumiko; Asano, Takeshi; Nomura, Atsushi; Nishino, Hoyoku (December 2003). "Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation". Journal of Natural Products. 66 (12): 1582–1585. doi:10.1021/np0302293. ISSN 0163-3864. PMID 14695801.
- ↑ Jump up to: 3.0 3.1 Soksawatmakhin, Sukanya; Boonyahotra, Wijit (January 2013). "Preliminary study of the applications of Ganoderma lucidum in chronic fatigue syndrome". Journal of Asian Association of Schools of Pharmacy. 2: 262–268. ISSN 0975-6299.
